Tonsillectomy is one of the most common surgical procedures in children, with an estimated yearly rate in the UK of 2.3/1000 for the population aged under 12 yr. Increasing attention is being paid to the control of perioperative pain in children with the development of validated pain scales and more vigorous employment of analgesic techniques. 1 However, the provision of adequate analgesia after tonsillectomy presents the clinician with dif®culties as this is a painful procedure and it may be associated with signi®cant bleeding into the airway. Opioids are frequently used and provide effective analgesia for tonsillectomy 2 but are associated with a high incidence of nausea and vomiting. 3 In addition, there are concerns about opioidinduced respiratory depression and sedation, which may make recovery hazardous after pharyngeal surgery, 4 5 particularly in children with a history of obstructive sleep apnoea. Non-steroidal anti-in¯ammatory drugs (NSAIDs) have a similar analgesic effect to opioids for tonsillectomy 5 and are opioid-sparing in the recovery period. 4 However, the perioperative use of NSAIDs has been limited because of concerns over increased postoperative bleeding, which has been demonstrated with ketorolac, 6 7 although apparently not for other NSAIDs. 8 Paracetamol has been shown to be an effective and relatively safe analgesic in children 9 10 British Journal of Anaesthesia 88 (1) and is often used to provide a background of analgesia after surgery, but appears to be insuf®ciently potent if used alone for tonsillectomy pain.
11
The current practice in our unit is to use a balanced approach 12 with a combination of regular paracetamol and NSAIDs plus opioid as needed to provide perioperative analgesia for tonsillectomy. 13 However, there is no published evidence to support the use of NSAIDs with paracetamol for perioperative analgesia in children. A recent study of children after appendectomy failed to show any additional morphine-sparing effect from combining paracetamol with diclofenac.
14 This contrasts with an adult study, which showed the combination of paracetamol and diclofenac to reduce postoperative morphine consumption compared with either drug alone. 15 The recently introduced cyclo-oxygenase type 2 (COX-2) inhibitors, such as rofecoxib, 16 may have advantages for analgesia in paediatric tonsillectomy. They have analgesic power equivalent to that of NSAIDs for dental extraction pain. 17 18 Their COX-2 selectivity produces minimal effect on platelet aggregation. In addition, rofecoxib has a syrup formulation, excellent oral bioavailability and a half-life of action of 17 h, allowing once-daily dosing. These properties potentially make it a good candidate for perioperative use in paediatrics to help reduce`tears at bedtime'. 19 Currently, there are no pharmacokinetic or pharmacodynamic data on the use of COX-2 antagonists in children. Rofecoxib 50 mg has been shown to be equianalgesic to ibuprofen 400 mg in the adult dental pain model. 17 We have used this measure of the potency of rofecoxib to estimate an equianalgesic paediatric dose (0.625 mg kg ±1 ) as being one-eighth of the paediatric ibuprofen dose (5 mg kg ±1 ). The aim of our randomized, double-blinded, placebocontrolled pragmatic clinical study was to examine whether combining a NSAID (ibuprofen 5 mg kg ±1 ) or COX-2 antagonist (rofecoxib 0.625 mg kg ±1 ) with paracetamol (20 mg kg ±1 ) before paediatric tonsillectomy would confer analgesic bene®ts without increasing intraoperative blood loss.
Methods
The study was approved by the hospital ethics committee. A Clinical Trials Exemption certi®cate was obtained from the Medicines Control Agency of the UK to allow the use of rofecoxib as an analgesic in children. After written informed parental consent and verbal child assent had been obtained, 103 children, ASA I or II, aged 3±15 yr, presenting for elective tonsillectomy or adenotonsillectomy, were entered in the trial. Using a computer-generated random number table, a hospital pharmacist allocated the children randomly to three groups: placebo, rofecoxib or ibuprofen. Both the patients and the investigators were blinded to the study group assignment. Exclusion criteria were sensitivity to NSAIDs, bleeding diathesis, renal or hepatic impairment and severe asthma (requiring recent hospital admission or oral corticosteroid therapy). On enrolment in the study, the children were familiarized with the Oucher visual analogue pain scale, which has been validated in children 20 and used previously to score tonsillectomy pain. 21 The children were premedicated 1 h before surgery with paracetamol syrup 20 mg kg ±1 and either placebo, ibuprofen 5 mg kg ±1 or rofecoxib 0.625 mg kg ±1 (syrups 0.25 ml kg ±1 to a maximum of 10 ml). Therefore, the maximum dose was ibuprofen 200 mg or rofecoxib 25 mg. Induction of anaesthesia was with propofol or sevo¯urane and the airway was secured with a reinforced laryngeal mask (53% of children) or endotracheal tube (47%). Atracurium 0.5 mg kg ±1 was used to facilitate intubation. Anaesthesia was maintained with iso¯urane in 33% oxygen/67% nitrous oxide and intraoperative analgesia was provided with fentanyl 1±2 mg kg ±1 . No NSAIDs, paracetamol or prophylactic antiemetic were given in theatre. Intraoperative blood loss was assessed by weighing swabs (assuming 1 g=1 ml blood) and by measuring losses to calibrated suction bottles.
A standardized postoperative analgesic regimen was prescribed of regular paracetamol (15 mg kg ±1 , 4 hourly) with oral ibuprofen (5 mg kg ±1 ) or oral codeine (1 mg kg ±1 ) to be administered at the child's request by the ward nursing staff. Pain was scored whenever supplementary analgesia was administered and also 4 and 8 h after premedication, when the the ®rst two postoperative doses of paracetamol were given. Children were considered to have required early supplementary analgesia if they received either ibuprofen or codeine within 2 h after surgery. Children were discharged home the day after surgery.
The primary outcome variable was the need for early postoperative analgesia. Secondary outcome variables were intraoperative blood loss, time to ®rst postoperative analgesia, Oucher pain scores, analgesic consumption in the ®rst 24 h, vomiting, antiemetic use and incidence of primary and secondary haemorrhage. The data were collected by the anaesthetist, theatre and ward nurses and subsequently validated by review of the clinical notes.
Differences among groups were compared using the Kruskal±Wallis test for non-parametric data, one-way analysis of variance for parametric data and the c 2 test or Fisher's exact test for nominal data. P<0.05 was considered signi®cant. A sample size calculation based on audit data from our hospital showed that 60% of children premedicated with paracetamol and receiving rectal diclofenac intraoperatively required early postoperative analgesia. Therefore, to show a 50% reduction in the need for early analgesia in the rofecoxib group, we estimated that 42 patients were required per group (power of 80% and P<0.05). To minimize the size of the placebo group, a blinded interim analysis was planned by the statistician at the halfway point. If this showed a greater need for early postoperative analgesia in the placebo group than the ibuprofen group, then recruitment to the placebo group would cease.
Results
Of the 103 children recruited, ®ve were excluded because of protocol violations (two were too young and three received diclofenac in theatre). The patient and surgical characteristics were comparable across the groups (Table 1) . There were no differences in the time from premedication to the start of surgery [78 (29) min; pooled mean (SD)], operation type (tonsillectomy or adenotonsillectomy), duration of surgery or dose of intraoperative fentanyl ( Table 1) .
The interim blinded analysis showed that more children in the placebo group received early postoperative analgesia than in the ibuprofen group (72 vs 38%; difference 34%, 95% con®dence interval 4±64%). Therefore recruitment to the placebo group was stopped at 18 children. Signi®cantly more children required early analgesia (within 2 h after surgery) in the rofecoxib group compared with the ibuprofen group (68 vs 43%; difference 25%, 95% con®dence interval 4±46%) ( Table 2 ). The pain scores at the time of administration of supplementary analgesia were signi®cantly higher in those children requesting early analgesia (median 60 vs 40, P<0.0001). By the time of the ®rst postoperative paracetamol dose, there was no difference in pain scores between the groups (Table 2 ). There was no difference between the groups in total analgesic consumption in the ®rst 24 h, in the incidence of vomiting or the need for antiemetic (Table 2 ).
There was greater surgical blood loss in children having adenotonsillectomy than in those having tonsillectomy [median (interquartile range) 2.6 (1.6±3.9) vs 0.71 (0.31±1.4); P<0.0001]. There was no signi®cant difference between the treatment groups in blood loss for either tonsillectomy or adenotonsillectomy (Fig. 1) , nor was there any difference in the incidence of primary (bleeding requiring intervention within 24 h) or secondary (bleeding requiring readmission) haemorrhage ( Table 2) . Two of the children required a second operation to achieve adequate haemostasis (one each in the placebo and ibuprofen groups). Both rofecoxib and ibuprofen were well tolerated by the children, with no refusal of medication and no episodes of bronchospasm, pruritis or dizziness. One child in the ibuprofen group developed a mild erythematous, non-itchy rash after surgery, which resolved within 4 h without treatment.
Discussion
Ibuprofen in combination with paracetamol as premedication reduced the need for early supplementary analgesia by almost 50% after tonsillectomy. The clinical importance of this ®nding is indicated by the higher pain scores at the time of supplementary analgesia in the children requiring early rescue. This equates to fewer distressed children on the ward 22% (4) 33% (13) 28% (11) 0.71 Antiemetic administered (n) 22% (4) 20% (8) 20% (8) 0.97 Primary haemorrhage (n) 5.5% (1) 2.5% (1) 5% (2) 0.83 Secondary haemorrhage (n)
11% (2) 7.5% (3) 2.5% (1) 0.30 in the early postoperative period in the ibuprofen group. This analgesic bene®t from the combination of paracetamol and ibuprofen lends support to our current practice of using NSAIDs for perioperative analgesia. Paracetamol 20 mg kg ±1 alone provided adequate analgesia for just 24% of the children in this study. This emphasizes the dif®culty in providing pain relief in children with contraindications to NSAIDs. A previous study of paediatric tonsillectomy has shown paracetamol (20 mg kg ±1 ) to be equivalent to diclofenac (1 mg kg ±1 ), but each drug alone was noted to provide inadequate overall analgesia. 11 These results provide some justi®cation for the use of NSAIDs in children with relative contraindications, such as controlled asthmatics, particularly in view of the recent demonstration of the safety of diclofenac in asthmatic children. 22 However, it should be noted that, although the dose of paracetamol (20 mg kg ±1 ) used in this study was our usual oral loading dose, recent studies have demonstrated improved analgesic ef®cacy with higher doses of oral (40 mg kg ±1 ) or rectal paracetamol (40±60 mg kg ±1 ), which achieve higher plasma concentrations. 9 10 It is possible that the use of a larger loading dose of paracetamol in our study would have produced an improved analgesic effect. Also of relevance to our study is the observation that the premedication of children having adenotonsillectomies with oral paracetamol elixir (40 mg kg ±1 ) has been shown to have no effect on the volume or pH of gastric contents at the time of operation. 23 The addition of rofecoxib to paracetamol failed to confer any additional analgesic bene®t compared with paracetamol alone. This was a surprising ®nding, which questions the role of COX-2 antagonists for perioperative analgesia. Previous perioperative studies in adults have demonstrated rofecoxib to have an analgesic ef®cacy equivalent to that of ibuprofen 17 18 and it has been shown to be opioid-sparing after spinal surgery. 24 When designing our study, in the absence of paediatric pharmacokinetic data, we calculated the dose of rofecoxib (0.625 mg kg ±1 ) such that a 40-kg child would receive the current UK maximum adult dose of 25 mg. Our rofecoxib dose calculation was based on the ®nding that, in adults, a dose of rofecoxib 50 mg is equianalgesic to 400 mg ibuprofen. 17 As the usual paediatric dose of ibuprofen is 5 mg kg ±1 , we expected a dose of rofecoxib 0.625 mg kg ±1 to be equianalgesic. This dose also allowed us to give equal volumes of the ibuprofen and rofecoxib drug syrups (0.25 ml kg ±1 ), which assisted with study blinding.
The study drugs were given more than 60 min before surgery, allowing approximately 100 min for rofecoxib absorption and the onset of analgesic action before arrival in the recovery unit. Data from dental extraction studies have indicated that the time to onset of analgesia for rofecoxib is similar to that of ibuprofen 18 and has been quoted by the manufacturer as 45 min. We have no evidence of a delayed analgesic effect of rofecoxib as the total analgesic consumption in the ®rst 24 h was similar across the groups. In seeking to explain our failure to demonstrate any bene®t, it is unlikely that our study was under-powered, as we have been able to show the bene®cial analgesic effect of ibuprofen.
This study looked for an additive analgesic effect of the combination of rofecoxib and paracetamol. The sites of action of both drugs may be relevant: paracetamol inhibits brain cyclo-oxygenase 25 and rofecoxib inhibits COX-2, which is expressed constitutively in the brain as well as being inducible in the periphery. 16 If both drugs were acting to inhibit the same brain cyclo-oxygenase, we could perhaps explain the lack of additive effect (if we assume that paracetamol is producing nearly maximal antagonism of brain COX). Alternatively, it is possible that inducible COX-2 does not play a major role in nociception in the early recovery period after tonsillectomy. Our ®ndings suggest that central cyclo-oxygenase and peripheral COX-1 are involved in mediating early pain after tonsillectomy.
The surgical blood loss seen during this study was similar to that reported previously from our institution. 13 There were no signi®cant differences in blood loss or in bleeding complications between the three groups. In designing the study, we wished to re¯ect our normal clinical practice so no restriction was placed upon surgical grade or technique employed for tonsillectomy. A retrospective power analysis showed that the study had limited power (23%) to demonstrate the largest difference seen between the groups because of the large variation in blood loss. That the observed distributions were so wide suggests that there are factors other than the perioperative use of NSAIDs that determine surgical bleeding.
The incidence of postoperative vomiting was 29% in the ®rst 24 h. This was without prophylactic antiemetic and is lower than that previously reported in this surgical population. 26 Previous studies of tonsillectomy have correlated postoperative vomiting with opioid use 3 and pain. 11 In our study, there were no signi®cant differences between the groups in vomiting or in the need for rescue antiemetic.
In conclusion, this clinical study emphasizes that paediatric tonsillectomy is a painful procedure requiring proactive analgesic strategies to provide a good quality of postoperative recovery. We have shown analgesic bene®t without increased risk of complications by combining ibuprofen with paracetamol for premedication. We failed to show an analgesic effect of rofecoxib in combination with paracetamol, suggesting that the COX-2 antagonists will require careful evaluation before their role in perioperative analgesia can be de®ned clearly. In particular, studies that compare COX-2 antagonists with paracetamol (which, coincidentally, also has a low incidence of gastric and haemostatic complications) will be particularly valuable. There is further scope for improving analgesia after tonsillectomy but we can commend the perioperative combination of ibuprofen with paracetamol as a useful strategy in children.
